ID   GBM-18-A3
AC   CVCL_S552
SY   GBM-18-A3 (MDR)
DR   Wikidata; Q54835467
RX   PubMed=1317362;
RX   PubMed=1653364;
CC   Selected for resistance to: ChEBI; CHEBI_23359; Colchicine.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:40; ABCB1.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S551 ! GBM-18
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
RX   PubMed=1317362; DOI=10.1002/ijc.2910510307;
RA   Moulton T.A., Jiang H., Guarini L., Fetell M.R., Fisher P.B.;
RT   "Induction of growth suppression and modification of gene expression
RT   in multi-drug-resistant human glioblastoma multiforme cells by
RT   recombinant human fibroblast and immune interferon.";
RL   Int. J. Cancer 51:373-378(1992).
//
RX   PubMed=1653364; DOI=10.1093/jnci/83.18.1307;
RA   Reddy P.G., Graham G.M., Datta S., Guarini L., Moulton T.A.,
RA   Jiang H.-P., Gottesman M.M., Ferrone S., Fisher P.B.;
RT   "Effect of recombinant fibroblast interferon and recombinant immune
RT   interferon on growth and the antigenic phenotype of multidrug-resistant
RT   human glioblastoma multiforme cells.";
RL   J. Natl. Cancer Inst. 83:1307-1315(1991).
//